Year-End Report

MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Firm
Client
Income
—
Expenses
$700,000

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

LobbyistCovered position, as disclosed
MICHAEL J EGING N/A
THOMAS JOHN FUSSARO N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

HR 2795 Patent Reform Act of 2005

LobbyistCovered position, as disclosed
MICHAEL J EGING N/A
THOMAS JOHN FUSSARO N/A

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2795 (110th)

Medical/Disease Research/Clinical Labs MED

PDUFA-IV Biologics FDA Appropriations

LobbyistCovered position, as disclosed
MICHAEL J EGING N/A
THOMAS JOHN FUSSARO N/A

Contacted: SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare Part B coverage issues Section 1861 (t)(2)(B) Social Security Act H.R. 3162, Children's Health and Medicare Protection Act

LobbyistCovered position, as disclosed
MICHAEL J EGING N/A
THOMAS JOHN FUSSARO N/A

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3162 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.